Seres Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -54.22M-91.58M-89.81M-99.11M-71.34M-90.11M-64.53M-66.58M76.41M125.91M
Depreciation and Depletion 1.46M2.02M0.99M
Share-based Compensation 0.21M2.07M9.69M16.86M17.36M16.64M8.34M8.82M20.22M25.48M34.10M20.97M
Gains from Sales and Divestitures 0.05M0.06M0.04M0.14M0.09M0.12M0.28M1.52M2.20M
Gains from Investment Securities 0.02M1.42M5.03M5.07M6.13M7.56M8.31M10.04M11.52M14.94M14.84M17.72M
Asset Writedowns and Impairment 3.27M
Non-cash Items 1.64M16.74M3.24M4.39M4.82M3.16M5.59M7.44M15.34M
Cash from Operations -5.32M-10.36M-40.84M43.92M-75.52M-62.85M-76.52M-93.61M6.69M-228.82M-117.35M-148.61M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.39M0.22M0.21M0.17M-0.45M-0.50M-0.69M0.24M
Amortization of Deferred Charges 0.28M0.55M2.53M0.70M1.14M1.41M
Depreciation & Amortization (CF) 0.09M0.19M0.73M4.21M7.26M7.86M7.60M6.58M5.95M6.63M6.24M5.47M
Change in Working Capital
Change in Receivables 1.78M7.60M-9.39M8.67M-8.67M
Change in Inventory 29.65M33.80M
Change in Account Payables 0.28M0.81M2.68M3.58M-0.86M-0.35M-1.46M-1.16M9.36M2.20M-11.58M-2.94M
Change in Accured Expenses 0.20M1.47M2.93M5.03M2.16M0.73M-2.91M3.77M43.02M3.34M15.84M-10.20M
Investing Activities
Capital Expenditures 0.17M1.00M4.36M21.49M4.68M1.94M1.00M0.59M9.57M9.82M7.97M0.38M
Divestments 141.27M
Change in Acquisitions & Divestments 136.39M246.49M158.31M136.09M16.90M59.98M169.62M140.47M22.98M
Cash from Investing Activities -0.18M-1.10M-137.13M-65.59M55.70M112.32M-30.52M-158.89M64.09M82.43M10.58M142.29M
Financing Activities
Other financing activities 0.42M
Debt Issuance and Repayment
Long-Term Debt Issuances 25.00M27.61M103.38M
Long-Term Debt Repayments 0.40M2.60M0.95M1.91M52.86M127.91M
Change in Capital Stock
Shares Issued 0.01M143.01M2.14M0.12M0.26M60.53M243.75M1.30M96.72M2.15M0.49M
Shares Repurchased 0.03M
Preferred Shares Issued 123.20M-0.02M
Misc.
Cash from Financing Activities 0.94M123.99M137.72M2.14M0.08M0.27M86.23M303.42M1.18M129.60M71.70M-90.37M
Exchange Rate Effect -0.00M-0.00M0.00M-0.00M
Change in Cash -4.56M112.53M-40.25M-19.53M-19.74M49.73M-20.81M50.92M71.95M-16.79M-35.07M-96.69M
Free Cash Flow -5.50M-11.36M-45.21M22.43M-80.20M-64.79M-77.52M-94.20M-2.88M-238.64M-125.33M-148.99M
Net Cash Flow -4.56M112.53M-40.25M-19.53M-19.74M49.73M-20.81M50.92M71.95M-16.79M-35.07M-96.69M